International Stem Cell Corporation’s Human Parthenogenetic Stem Cells To Be Used In Germany In The Development Of Treatments For Neural Disease

Monday, March 3rd, 2008

International Stem Cell Corporation (OTCBB:ISCO) announced that its human parthenogenetic stem cell lines will be used in Germany in studies aimed at creating specific cell types to treat human neural diseases such as Parkinson's disease. The work will be headed by Dr. Albrecht Mueller of the University of Wuerzburg, Wuerzburg, Germany ...

Spine Surgery Yields Greater Benefits Over Nonsurgical Treatments

Monday, February 25th, 2008

A research study by orthopedic spine, back and neck surgeon at Rush University Medical Center Dr. Howard An and colleagues found that patients who underwent surgery for spinal stenosis showed significantly more improvement in all primary outcomes than did patients who were treated nonsurgically. The study findings were published in ...

No Real Differences Noted In Kidney Failure Treatments

Wednesday, February 20th, 2008

According to a recent article published in The Journal of the American Medical Association, different treatments for acute kidney failure lead to nearly the same mortality rate and other similar clinical outcomes. The meta-analysis was performed by Neesh Pannu of the University of Alberta, Edmonton, Canada and colleagues. The researchers focused ...